Get the Stockscreener App
7.89
0.00%
0.00
Avalo Therapeutics Inc stock is traded at $7.89, with a volume of 242.14K.
It is up +0.00% in the last 24 hours and up +63.02% over the past month.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
See More
Previous Close:
$7.89
Open:
$7.73
24h Volume:
242.14K
Relative Volume:
2.28
Market Cap:
$85.43M
Revenue:
$1.93M
Net Income/Loss:
$-7.96M
P/E Ratio:
-0.00223
EPS:
-3530.8178
Net Cash Flow:
$-36.78M
1W Performance:
+17.94%
1M Performance:
+63.02%
6M Performance:
-6.29%
1Y Performance:
-28.60%
1-Day Range:
$7.5139
$8.7529
1-Week Range:
$6.21
$8.7529
52-Week Range:
$3.39
$16.00
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Name
Avalo Therapeutics Inc
Sector
Industry
Phone
410-522-8707
Address
1500 LIBERTY RIDGE DRIVE, WAYNE
Compare AVTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
7.89 | 85.43M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| Mar-25-25 | Initiated | Jefferies | Buy |
| Mar-25-25 | Initiated | Stifel | Buy |
| Feb-28-25 | Initiated | Piper Sandler | Overweight |
| Feb-21-25 | Initiated | Wedbush | Outperform |
| Dec-19-24 | Initiated | BTIG Research | Buy |
| Oct-24-24 | Initiated | H.C. Wainwright | Neutral |
| Apr-16-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-24-21 | Initiated | RBC Capital Mkts | Outperform |
View All
Avalo Therapeutics Inc Stock (AVTX) Latest News
Risk adjusted return profile for Avalo Therapeutics Inc. analyzedFree Real-Time Analysis With Entry Targets - Newser
Pattern recognition hints at Avalo Therapeutics Inc. upsideDaily Pick Forecast with Entry Zones - Newser
What makes Avalo Therapeutics Inc. stock attractive to long term investorsShort-Term Upside Breakout Forecast System - Newser
Published on: 2025-08-01 20:46:45 - Newser
What institutional investors are buying Avalo Therapeutics Inc. stockEntry Signal Signals To Watch Now - jammulinksnews.com
Why is Avalo Therapeutics Inc. stock attracting strong analyst attentionBest Dividend Forecasts To Watch Now - jammulinksnews.com
How volatile is Avalo Therapeutics Inc. stock compared to the marketTop Growth Tracker With Low Risk - jammulinksnews.com
Chart based exit strategy for Avalo Therapeutics Inc.Equity Portfolio Outlook and Performance Summary - Newser
What momentum shifts mean for Avalo Therapeutics Inc.Price Movement and Market Sentiment Analysis - Newser
How to recover losses in Avalo Therapeutics Inc. stockReal Time Screener for Growth Trades - Newser
How to forecast Avalo Therapeutics Inc. trends using time seriesAI Pattern Recognition and Trade Prediction - Newser
Buy Signal for Avalo Therapeutics Inc. Stock Key Technical Indicators to WatchInvestment Timing Strategy with Market Filters - Newser
How does Avalo Therapeutics Inc. generate profit in a changing economyChart Pattern Growth Plan For Smart Trading - jammulinksnews.com
What makes Avalo Therapeutics Inc. stock price move sharplyChart Pattern Planner With Low Risk - jammulinksnews.com
Why did AVTX's Q3 earnings fall short of forecasts? - AInvest
How strong is Avalo Therapeutics Inc. company’s balance sheetAdvanced Screener Ideas For Every Investor - jammulinksnews.com
Analysts Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Price Target at $30.00 - Defense World
How does Avalo Therapeutics Inc. compare to its industry peersBreakout Stocks Recommendation With Proven Results - jammulinksnews.com
When is Avalo Therapeutics Inc. stock expected to show significant growthSwing Trade Picks With Low Risk - jammulinksnews.com
Is Avalo Therapeutics Inc. still worth holding after the dipTechnical Setup Guide for Daily Watchlist - Newser
Published on: 2025-07-30 04:37:25 - Newser
Risk vs reward if holding onto Avalo Therapeutics Inc.Weekly Movement Forecast With Chart Signals - Newser
Should you wait for a breakout in Avalo Therapeutics Inc.Daily Market Momentum and Pressure Analysis - Newser
Recovery Setup Building in Avalo Therapeutics Inc. Experts SayInvestment Playbook for Growing Markets Shared - metal.it
Published on: 2025-07-29 12:11:01 - metal.it
Developing predictive dashboards with Avalo Therapeutics Inc. dataHigh Win Rate Strategy with Stop Protection - Newser
What institutions are buying Avalo Therapeutics Inc. stock nowFree Capital Efficiency Optimized Stock Alerts - Newser
What is Avalo Therapeutics Inc. company’s growth strategyCapitalize on emerging market sectors - jammulinksnews.com
What are analysts’ price targets for Avalo Therapeutics Inc. in the next 12 monthsBest Dividend Tips With High Returns - jammulinksnews.com
Should I hold or sell Avalo Therapeutics Inc. stock in 2025Free Capital Allocation Plans - jammulinksnews.com
What are the technical indicators suggesting about Avalo Therapeutics Inc.Invest confidently with real-time market updates - jammulinksnews.com
Real time pattern detection on Avalo Therapeutics Inc. stockFree Chart Alert System With Entry Targets - Newser
Is Avalo Therapeutics Inc. still worth holding after the dip Free Stable Entry High Return Opportunities - Newser
What is the dividend policy of Avalo Therapeutics Inc. stockBuild a portfolio that delivers consistent profits - jammulinksnews.com
Moving Average Trends for Avalo Therapeutics Inc. Stock: What They IndicateFree Access to Community with 300% Return - Newser
Why Avalo Therapeutics Inc. stock attracts strong analyst attentionWatchlist Winner Update - Newser
What analysts say about Avalo Therapeutics Inc. stockSky-high profits - PrintWeekIndia
What drives Avalo Therapeutics Inc. stock priceHigh-yield investments - PrintWeekIndia
Avalo Therapeutics Inc. Stock Analysis and ForecastAccelerated capital growth - PrintWeekIndia
When is the best time to buy Avalo Therapeutics Inc. stockExponentially increasing returns - jammulinksnews.com
Avalo Therapeutics Inc Stock (AVTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):